Tacrolimus (FK 506) in kidney transplantation: Five-year survival results of the US multicenter, randomized, comparative trial

被引：28
|
作者：
Vincenti, F [1 ]
机构：
[1] Univ Calif San Francisco, Kidney Transplant Serv, San Francisco, CA 94143 USA
来源：
TRANSPLANTATION PROCEEDINGS | 2001年 / 33卷 / 1-2期
关键词：
D O I：
10.1016/S0041-1345(00)02312-5
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：1019 / 1020
页数：2
相关论文
共 50 条
  • [21] Randomized Control Trial of Composite Cuspal Restorations: Five-year Results
    Fennis, W. M.
    Kuijs, R. H.
    Roeters, F. J.
    Creugers, N. H.
    Kreulen, C. M.
    JOURNAL OF DENTAL RESEARCH, 2014, 93 (01) : 36 - 41
  • [22] Histopathologic findings from 2-year protocol biopsies from a US multicenter kidney transplant trial comparing tacrolimus versus cyclosporine: A report of the FK506 Kidney Transplant Study Group
    Solez, K
    Vincenti, F
    Filo, RS
    TRANSPLANTATION, 1998, 66 (12) : 1736 - 1740
  • [23] Five-year follow-up of a trial comparing tacrolimus and cyclosporine microemulsion in liver transplantation
    González-Pinto, IM
    Rimola, A
    Margarit, C
    Cuervas-Mons, V
    Abradelo, M
    Alvarez-Laso, C
    Londoño, MC
    Bilbao, I
    Sánchez-Turrón, V
    TRANSPLANTATION PROCEEDINGS, 2005, 37 (04) : 1713 - 1715
  • [24] An open-label, concentration-ranging trial of FK506 in primary kidney transplantation - A report of the United States multicenter FK506 kidney transplant group
    Laskow, DA
    Vincenti, F
    Neylan, JF
    Mendez, R
    Matas, AJ
    TRANSPLANTATION, 1996, 62 (07) : 900 - 905
  • [25] COMPARING NEPHROTOXICITY OF FK-506 AND CYCLOSPORINE REGIMENS AFTER LIVER-TRANSPLANTATION - PRELIMINARY-RESULTS FROM US MULTICENTER TRIAL
    PORAYKO, MK
    GONWA, TA
    KLINTMALM, GB
    WIESNER, RH
    TRANSPLANTATION PROCEEDINGS, 1995, 27 (01) : 1114 - 1116
  • [26] WHOLE-BLOOD AND PLASMA-LEVELS OF FK-506 AFTER LIVER-TRANSPLANTATION - RESULTS FROM THE US MULTICENTER TRIAL
    BACKMAN, L
    LEVY, MF
    KLINTMALM, G
    TRANSPLANTATION PROCEEDINGS, 1995, 27 (01) : 1124 - 1124
  • [27] Five-Year Results of a Randomized Trial Comparing De Novo Sirolimus and Cyclosporine in Renal Transplantation: The Spiesser Study
    Lebranchu, Y.
    Snanoudj, R.
    Toupance, O.
    Weestel, P-F
    de Ligny, B. Hurault
    Buchler, M.
    Rerolle, J-P
    Thierry, A.
    Moulin, B.
    Subra, J-F
    Deteix, P.
    Le Pogamp, P.
    Finzi, L.
    Etienne, I.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 (07) : 1801 - 1810
  • [28] Heparin-bonded Dacron or polytetrafluorethylene for femoropopliteal bypass: Five-year results of a prospective randomized multicenter clinical trial
    Devine, C
    McCollum, C
    JOURNAL OF VASCULAR SURGERY, 2004, 40 (05) : 924 - 931
  • [29] A randomized trial of tacrolimus (FK506) versus total lymphoid irradiation for the control of repetitive rejection after cardiac transplantation
    Keogh, AM
    Arnold, RH
    Macdonald, PS
    Hawkins, RC
    Morgan, GW
    Spratt, PM
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2001, 20 (12): : 1331 - 1334
  • [30] TACROLIMUS CONCENTRATION/DOSE RATIO INFLUENCES FIVE YEAR SURVIVAL RATE AFTER KIDNEY TRANSPLANTATION
    Thoelking, Gerold
    Steinke, Julia
    Schuette-Nuetgen, Katharina
    Pavenstaedt, Hermann
    Suwelack, Barbara
    Reuter, Stefan
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2017, 32
12345